CDK/HDAC-IN-3

CDK/HDAC-IN-3 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:CDK/HDAC-IN-3
CAS:2944087-54-9
Package:25mg;1970USD|50mg;2580USD|100mg;3400USD
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Products Intro: Product Name:CDK/HDAC-IN-3
CAS:2944087-54-9
Purity:98% Package:1g
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:CDK/HDAC-IN-3
CAS:2944087-54-9
Package:1removed

CDK/HDAC-IN-3 manufacturers

  • CDK/HDAC-IN-3
  • CDK/HDAC-IN-3 pictures
  • $1970.00
  • 2026-05-11
  • CAS:2944087-54-9
  • Purity:
  • Supply Ability: 10g
CDK/HDAC-IN-3 Basic information
Product Name:CDK/HDAC-IN-3
Synonyms:CDK/HDAC-IN-3;1H-Pyrazole-3-carboxamide, N-[4-[[(2-aminophenyl)amino]carbonyl]phenyl]-4-[(2,6-dichlorobenzoyl)amino]-
CAS:2944087-54-9
MF:C24H18Cl2N6O3
MW:509.34
EINECS:
Product Categories:
Mol File:2944087-54-9.mol
CDK/HDAC-IN-3 Structure
CDK/HDAC-IN-3 Chemical Properties
Boiling point 594.904±50.00 °C(Press: 760.00 Torr)(predicted)
density 1.573±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
form Solid
pka11.040±0.70(predicted)
color White to yellow
Safety Information
MSDS Information
CDK/HDAC-IN-3 Usage And Synthesis
UsesCDK/HDAC-IN-3 is an orally active HDACs/CDKs dual inhibitor. CDK/HDAC-IN-3 has potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2 and HDAC3 with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28nM and 82.87 nM. CDK/HDAC-IN-3 can be used for the acute myeloid leukemia (AML) [1].
in vivo

CDK/HDAC-IN-3 (compound 33a) (i.v., p.o.; 5, 25 mg/kg) has relatively adequate oral bioavailability[1].

Animal Model:Sprague-Dawley male rats (220-350 g)[1]
Dosage:5 mg/kg and 25 mg/kg
Administration:IV and PO
Result:
PK parametersi.v (5 mg/Kg)p.o (25 mg/Kg)
Cmax(ng/L)3644.001426.00
T1/2(h)0.111.37
TMax(h)NA0.75
Clearance (mL/h/kg)5307.001726.00
MRT (h)0.391.27
AUC (ng.h/mL)836.002368.00
F%NA56.70%
References[1] Liu Y, et al. Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells. Eur J Med Chem. 2023;249:115140. DOI:10.1016/j.ejmech.2023.115140
CDK/HDAC-IN-3 Preparation Products And Raw materials
Tag:CDK/HDAC-IN-3(2944087-54-9) Related Product Information